Dr. Reddy's Javygtor 100mg Tablets Recall: Failed Impurities Risk
Dr. Reddy's recalls 100mg Javygtor tablets due to failed impurities/degradation. Affected lots expire by 08/31/2025. Stop using if you have these specific lots.
Recall notice
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 100mg Javygtor tablets that may have failed impurities or degradation. This could affect medication safety, so affected users should stop using the product and contact their doctor. Read more at govinfonow.com/recall/32399-dr-reddy-s-javygtor-100mg-tablets-recall-failed-impurities-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32399-dr-reddy-s-javygtor-100mg-tablets-recall-failed-impurities-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0117-2025
Cite this page
“Dr. Reddy's Javygtor 100mg Tablets Recall: Failed Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32399-dr-reddy-s-javygtor-100mg-tablets-recall-failed-impurities-risk. Based on FDA recall #D-0117-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0117-2025%22&limit=1).
Why it’s dangerous
The tablets may contain impurities or degrade, which could affect medication safety. This might lead to ineffective treatment or adverse reactions for patients using them.
Who’s affected
Prescription users of Javygtor tablets who have the specific lots listed in the recall. People with cystic fibrosis who rely on this medication are most at risk.
How to tell if you have this one
Check the product label for the lot numbers: T2300653 (expires 01/31/2025), T2303956, T2303750 (expires 06/30/2025), T2304190, T2304987 (expires 08/31/2025), or T2302026 (expires 03/31/2025), T2302526 (expires 05/31/2025).
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Label
Look for the lot numbers listed in the recall to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 26 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0117-2025 (November 22, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0117-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.